Recall events
/
Event 96308
Event summary
Timeline bucket February 17, 2025
Product types Drug
Classifications Class II
Statuses Ongoing
Recalling firm wording Safecor Health, LLC
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
5 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 5
Ergocalciferol - Vitamin D Supplement - 10 mcg (400 Units) per 0.05 mL Oral Syringe, Delivers: 0.05 mL Oral Solution, Mfg by: Westminster, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: 69367028302.
D-0250-2025
Recall number D-0250-2025
Initiated February 17, 2025
Classification Class II
Status Ongoing
Quantity 3069 Oral Syringes
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Code information Lot #: 24300812, Exp 01/31/2025; 24530836, Exp 07/19/2025
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[15066]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 5
Simethicone 20 mg per 0.3 mL Oral Syringe, Delivers: 0.3 mL, Oral Drops, Mfg By: Rugby, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: 00536130375.
D-0251-2025
Recall number D-0251-2025
Initiated February 17, 2025
Classification Class II
Status Ongoing
Quantity 10992 Oral Syringes
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Code information Lot #s: 24201295, Exp 02/05/2025; 24210364, Exp 02/20/2025; 24231720, Exp 02/27/2025; 24500770, Exp 06/26/2025; 24471182, Exp 06/20/2025; 25031031, Exp 07/22/2025.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[658]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 5
Ferrous Sulfate 7.5 mg Iron/0.5 mL Oral Syringe, Delivers: 0.5 mL, Iron Supplement Drops, Mfg by: Akron Pharma, Pkg by: Safecor, Columbus, OH 43204. NDC: a) 71399748005, b) 39328055750, c) 69618007059.
D-0252-2025
Recall number D-0252-2025
Initiated February 17, 2025
Classification Class II
Status Ongoing
Quantity 1535 Oral Syringes
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Code information Lot #s: a) 24250093, Exp 03/07/2025; 24321592, Exp 04/04/2025; 24280320, Exp 03/27/2025; b) 24371268, Exp 04/19/2025; c) 24400519, Exp 04/07/2025; 24500768, Exp 06/24/2025; 25040972, Exp 07/25/2025.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[704]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 5
Lorazepam 0.5 mg per 0.25 mL Oral Syringe, Delivers: 0.25 mL, Oral Concentrate, Rx Only, Refrigerate, Mfg by: PAI, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: a) 00054353244, b) 00121077001, c) 65162068784.
D-0253-2025
Recall number D-0253-2025
Initiated February 17, 2025
Classification Class II
Status Ongoing
Quantity 3465 Oral Syringes
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Code information Lot #s: a) 24210274, Exp 01/31/2025; 24401700, Exp 04/25/2025; b) 24251067, Exp 03/25/2025; 24421733, Exp 06/03/2025; c) 24261384, Exp 03/24/2025; 24370127, Exp 04/28/2025.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[662]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 5
Morphine Sulfate 5 mg per 0.25 mL Oral Syringe, Delivers: 0.25 mL, Oral Solution, Rx Only, Mfg by: Hikma, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: a) 00406800312, b) 00406800330, c) 00054051750.
D-0254-2025
Recall number D-0254-2025
Initiated February 17, 2025
Classification Class II
Status Ongoing
Quantity 12390 Oral Syringes
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Code information Lot #s: a) 24220672, Exp 02/19/2025; 24280145, Exp 03/18/2025; 24240711, Exp 03/19/2025; b) 24180729, Exp 01/23/2025; 25030427, Exp 07/17/2025; c) 24360865, 24360864, Exp 03/31/2025; 24480235, Exp 06/21/2025.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[655]
FDA event record
· Exact recall-number query on openFDA
